Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase 1 placebo-controlled clinical trial to evaluate the safety and immunogenicity of SAAVI DNA-C2 vaccine boosted by SAAVI MVA-C vaccine in HIV uninfected healthy vaccinia naive adult participants in South Africa and the United States
Description
HVTN 073 (SAAVI 102) is a Phase I clinical trial to evaluate the safety and immunogenicity of SAAVI DNA-C2 prime / SAAVI MVA-C boost.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.